Vectura Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Chippenham United Kingdom (1997)
Status: Acquired by Carlyle Group (2021)

Organization Overview

First Clinical Trial
2006
NCT01683292
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Vectura Group | Vectura Limited | Vectura Ltd